Factors associated with improvement in guideline-based use of ICDs in eligible heart failure patients

PACE - Pacing and Clinical Electrophysiology

Volumn 35, Issue 2, 2012, Pages 135-145

  Mehra, Mandeep R ^a   Albert, Nancy M ^b   Curtis, Anne B ^c   Gheorghiade, Mihai ^d   Heywood, J Thomas ^e   Liu, Yang ^f   O'Connor, Christopher M ^g   Reynolds, Dwight ^h   Walsh, Mary Norine ⁱ   Yancy, Clyde W ^d   Fonarow, Gregg C ^j  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e SCRIPPS CLINIC   (United States)

^f MEDTRONIC INC   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

ⁱ St Vincent Heart Center of Indiana   (United States)

^j UCLA MEDICAL CENTER   (United States)

more..

Author keywords

evidence based medicine; heart failure; implantable cardioverter defibrillator; quality of care

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POTASSIUM; SODIUM; UREA;

ADULT; AFRICAN AMERICAN; AGE; AGED; ANGIOPLASTY; ANTICOAGULANT THERAPY; ARTICLE; CARDIAC PATIENT; CHOLESTEROL BLOOD LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; DEFIBRILLATOR; DEPRESSION; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DRUG USE; EDEMA; EUROPEAN AMERICAN; FEMALE; GENDER; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICAL HISTORY; MEDICAL PRACTICE; MEDICARE; PATIENT EDUCATION; PHYSICIAN; POTASSIUM BLOOD LEVEL; PRACTICE GUIDELINE; QRS COMPLEX; RACE; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; DEFIBRILLATORS, IMPLANTABLE; ELIGIBILITY DETERMINATION; FEMALE; GUIDELINE ADHERENCE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 84856754275     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2011.03279.x     Document Type: Article

References (19)

1. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, et al., Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883. (Pubitemid 34984635)
2. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, et al., Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237. (Pubitemid 40110811)
3. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, et al., Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004; 350: 2151-2158. (Pubitemid 38637995)
4. Kadish A, Mehra M,. Heart failure devices: Implantable cardioverter-defibrillators and biventricular pacing therapy. Circulation 2005; 111: 3327-3335. (Pubitemid 40875007)
5. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, et al., American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation 2005; 112: e154-e235.
6. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS, Gillinov AM, et al., American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). Circulation 2008; 117: e350-e408. (Pubitemid 351771339)
7. Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, Konstam MA, et al,. 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009; 119: 1977-2016.
8. Fonarow GC, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, et al,. Heart failure care in the outpatient cardiology practice setting: Findings from IMPROVE HF. Circ Heart Fail 2008; 1: 98-106.
9. Ruskin JN, Camm AJ, Zipes DP, Hallstrom AP, McGrory-Usset ME,. Implantable cardioverter defibrillator utilization based on discharge diagnoses from Medicare and managed care patients. J Cardiovasc Electrophysiol 2002; 13: 38-43. (Pubitemid 34113618)
10. Mehra MR, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, et al,. Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure: Findings from IMPROVE HF. Heart Rhythm 2009; 6: 1727-1734.
11. Fonarow GC, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, McBride ML, Inge PJ, et al,. Improving evidence-based care for heart failure in outpatient cardiology practices: Primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). Circulation 2010; 122: 585-596.
12. Fonarow GC, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, et al,. Improving the use of evidence-based heart failure therapies in the outpatient setting: The IMPROVE HF performance improvement registry. Am Heart J 2007; 154: 12-38. (Pubitemid 46929005)
13. Hernandez AF, Fonarow GC, Liang L, Al-Khatib SM, Curtis LH, LaBresh KA, Yancy CW, et al,. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA 2007; 298: 1525-1532. (Pubitemid 47529386)
14. Thomas KL, Al-Khatib SM, Kelsey RC II, Bush H, Brosius L, Velazquez EJ, Peterson ED, et al,. Racial disparity in the utilization of implantable cardioverter-defibrillators among patients with prior myocardial infarction and an ejection fraction of ≤35%. Am J Cardiol 2007; 100: 924-929. (Pubitemid 47368097)
15. Chan PS, Birkmeyer JD, Krumholz HM, Spertus JA, Nallamothu BK,. Racial and gender trends in the use of implantable cardioverter-defibrillators among Medicare beneficiaries between 1997 and 2003. Congest Heart Fail 2009; 15: 51-57.
16. Gauri AJ, Davis A, Hong T, Burke MC, Knight BP,. Disparities in the use of primary prevention and defibrillator therapy among blacks and women. Am J Med 2006; 119: 167.e17-167.e21.
17. Shah B, Hernandez AF, Liang L, Al-Khatib SM, Yancy CW, Fonarow GC, Peterson ED,. Get With The Guidelines Steering Committee. Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: Data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry. J Am Coll Cardiol 2009; 53: 416-422.
18. Ezekowitz JA, Rowe BH, Dryden DM, Hooton N, Vandermeer B, Spooner C, McAlister FA,. Systematic review: Implantable cardioverter-defibrillators for adults with left ventricular systolic dysfunction. Ann Intern Med 2007; 147: 251-262. (Pubitemid 351664582)
19. Al-Khatib SM, Hellkamp A, Curtis J, Mark D, Peterson E, Sanders GD, Heidenreich PA, et al,. Non-evidence-based ICD implantations in the United States. JAMA 2011; 305: 43-49.